Eisai China is a multinational company which focuses on the development and commercialization of pharmaceutical products. Eisai
China has entered China market for over 30 years with strong R&D, manufacture and commercial operation capability to form a
diverse product portfolio and wide coverage network, benefiting Chinese patients and the public.
Eisai China look forward to exploring more opportunities for collaboration with you in neuroscience, oncology, gastrointestinal,
immunology and innovative business, including pharmaceutics, diagnosis, medical devices, consumer health, digital therapy and
other high potential areas.